首页 > 最新文献

Annals of Plastic Surgery最新文献

英文 中文
Impact of Collagenase Injection on Dupuytren Disease Treatment in Japan: A Comprehensive Survey of Trends. 胶原酶注射对日本杜普伊特伦氏病治疗的影响:趋势综合调查。
IF 1.4 4区 医学 Q3 SURGERY Pub Date : 2024-08-12 DOI: 10.1097/SAP.0000000000004076
Hidemasa Yoneda, James Curley, Michiro Yamamoto, Hitoshi Hirata

Background: Collagenase Clostridium histolyticum (CCH) injection, an effective enzymatic fasciotomy treatment for Dupuytren disease (DD), was abruptly withdrawn from the healthcare market outside the United States in 2020. The impact on patients, physicians and hospitals of this helpful surgical alternative no longer being available has been little studied.

Methods: To investigate the impact of the withdrawal of CCH in Japan, we used the National Database Open Data Japan from 2014 to 2020. Published by the government, it contains summary data of the National Database of Health Insurance Claims and Specific Health Checkups of Japan. We extracted the numbers of CCH injections with Xiaflex, the product name in Japan, and surgeries identified by "Dupuytren contracture surgery codes." Each treatment was further parsed into one of 12 predefined regions in which it had taken place and by whether it had been delivered on an inpatient or outpatient basis.

Results: From its introduction in 2015, the number of DD patients treated with CCH increased in each successive year, reaching a peak in 2019, while the number of surgeries decreased with time. After the withdrawal in 2020, the number of surgeries increased to 1.5 times the 2019 number notwithstanding the impact of COVID-19, but the total number of patients treated decreased by 43%. In the initial regional analysis, CCH accounted for approximately 40% of all DD treatments in the less populous areas, with the exception of the Tohoku region, and more than 50% in the other regions. By 2019, the share of CCH treatment had increased in all regions. There was no significant correlation between the number of hand surgeons authorized to use CCH and the number of CCH cases within each region.

Conclusions: CCH increased treatment options for patients and surgeons. The withdrawal of this valuable pharmaceutical resulted in an increase in the number of surgeries amidst a decrease in the total number of treatments and lost opportunities for patients.

背景:胶原酶溶解梭菌(CCH)注射液是治疗杜普伊特伦病(DD)的一种有效的酶法筋膜切开术,但该药物于2020年突然从美国以外的医疗市场撤出。对于这种有用的手术替代疗法不再可用对患者、医生和医院的影响,研究很少:为了调查 CCH 退出对日本的影响,我们使用了 2014 年至 2020 年的日本国家数据库开放数据。该数据库由政府发布,包含日本健康保险索赔和特定健康检查国家数据库的汇总数据。我们提取了使用日本产品名称 "Xiaflex "的CCH注射次数,以及根据 "杜普伊特伦挛缩症手术代码 "确定的手术次数。每项治疗都被进一步解析为 12 个预定义地区中的一个,并按住院或门诊的方式进行:自 2015 年引入以来,接受 CCH 治疗的 DD 患者人数逐年增加,并于 2019 年达到峰值,而手术次数则随着时间的推移而减少。2020 年撤出后,尽管受到 COVID-19 的影响,手术数量增至 2019 年的 1.5 倍,但治疗的患者总数减少了 43%。在最初的地区分析中,除东北地区外,在人口较少的地区,慢性阻塞性肺疾病治疗约占所有 DD 治疗的 40%,而在其他地区则超过 50%。到 2019 年,CCH 治疗在所有地区的比例都有所上升。每个地区获准使用CCH的手外科医生数量与CCH病例数量之间没有明显的相关性:结论:CCH 增加了患者和外科医生的治疗选择。这一珍贵药品的停用导致手术数量增加,而治疗总数却减少,患者失去了治疗机会。
{"title":"Impact of Collagenase Injection on Dupuytren Disease Treatment in Japan: A Comprehensive Survey of Trends.","authors":"Hidemasa Yoneda, James Curley, Michiro Yamamoto, Hitoshi Hirata","doi":"10.1097/SAP.0000000000004076","DOIUrl":"https://doi.org/10.1097/SAP.0000000000004076","url":null,"abstract":"<p><strong>Background: </strong>Collagenase Clostridium histolyticum (CCH) injection, an effective enzymatic fasciotomy treatment for Dupuytren disease (DD), was abruptly withdrawn from the healthcare market outside the United States in 2020. The impact on patients, physicians and hospitals of this helpful surgical alternative no longer being available has been little studied.</p><p><strong>Methods: </strong>To investigate the impact of the withdrawal of CCH in Japan, we used the National Database Open Data Japan from 2014 to 2020. Published by the government, it contains summary data of the National Database of Health Insurance Claims and Specific Health Checkups of Japan. We extracted the numbers of CCH injections with Xiaflex, the product name in Japan, and surgeries identified by \"Dupuytren contracture surgery codes.\" Each treatment was further parsed into one of 12 predefined regions in which it had taken place and by whether it had been delivered on an inpatient or outpatient basis.</p><p><strong>Results: </strong>From its introduction in 2015, the number of DD patients treated with CCH increased in each successive year, reaching a peak in 2019, while the number of surgeries decreased with time. After the withdrawal in 2020, the number of surgeries increased to 1.5 times the 2019 number notwithstanding the impact of COVID-19, but the total number of patients treated decreased by 43%. In the initial regional analysis, CCH accounted for approximately 40% of all DD treatments in the less populous areas, with the exception of the Tohoku region, and more than 50% in the other regions. By 2019, the share of CCH treatment had increased in all regions. There was no significant correlation between the number of hand surgeons authorized to use CCH and the number of CCH cases within each region.</p><p><strong>Conclusions: </strong>CCH increased treatment options for patients and surgeons. The withdrawal of this valuable pharmaceutical resulted in an increase in the number of surgeries amidst a decrease in the total number of treatments and lost opportunities for patients.</p>","PeriodicalId":8060,"journal":{"name":"Annals of Plastic Surgery","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141992215","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Employer-Sponsored Medicare Advantage Plans and the 2018 Therapy Cap Repeal: Reduced Overall Spending Does Not Constrain Out-of-Pocket Costs. 雇主赞助的医疗保险优势计划与 2018 年治疗上限的废除:总体支出的减少并未限制自付费用。
IF 1.4 4区 医学 Q3 SURGERY Pub Date : 2024-08-06 DOI: 10.1097/SAP.0000000000004074
Joseph N Fahmy, Lingxuan Kong, Lu Wang, Kevin C Chung

Background: Policy impacting traditional Medicare beneficiaries may have unintended effects for privately insured patients. After the repeal of a longstanding $1500 outpatient therapy cap in 2018, we aimed to evaluate if this policy change was associated with differences in use of cost of postoperative therapy after common hand surgeries, including carpal tunnel release, trigger finger release, ganglion cyst excision, De Quervain tenosynovitis release, carpometacarpal arthroplasty, and distal radius fracture open reduction/internal fixation or percutaneous pinning.

Methods: The Medicare Supplement and Coordination of Benefits files from Marketscan were used. Frequency of therapy appointments, overall costs, and out-of-pocket costs were obtained. A segmented interrupted time series with Poisson and log-transformed linear regression was performed.

Results: No significant monthly change in odds of therapy use was found in the postpolicy period for patients who underwent trigger finger release, carpal tunnel release, Ganglion cyst excision, De Quervain tenosynovitis release, carpometacarpal arthroplasty, or distal radius fracture, pinning, or open reduction/internal fixation. Overall cost decreased in the postpolicy period by 2% for comprehensive plans (95% confidence interval [CI]: -0.03 to -0.01, P < 0.001), by 7% for those with exclusive provider organizations (95% CI: -0.10 to -0.04, P < 0.001), by 1% for HMOs (95% CI: -0.01 to 0.002, P = 0.01), and by 3% for preferred provider organizations (95% CI: -0.03 to -0.02, P < 0.001). In the postpolicy period, no monthly change in out-of-pocket cost was observed for patients with comprehensive, exclusive provider organization, health maintenance organization, preferred provider organization, or point of service with capitation insurance plans.

Conclusions: Patients with employer-sponsored Medicare Advantage plans experienced increased out-of-pocket costs for therapy despite lower net costs. These data highlight an urgent need for policy ensuring that patients benefit when overall costs of care decrease.

背景:影响传统医疗保险受益人的政策可能会对私人投保的患者产生意想不到的影响。在 2018 年废除长期存在的 1500 美元门诊治疗上限后,我们旨在评估这一政策变化是否与常见手部手术(包括腕管松解术、扳机指松解术、神经节囊肿切除术、De Quervain 腱鞘炎松解术、腕掌关节成形术和桡骨远端骨折切开复位/内固定术或经皮穿刺固定术)后使用术后治疗费用的差异有关:方法:使用 Marketscan 的医疗保险补充计划和协调福利档案。方法:使用 Marketscan 的医疗保险补充计划和协调福利档案,获取治疗预约频率、总费用和自付费用。采用泊松和对数变换线性回归进行分段间断时间序列分析:结果:对于接受扳机指松解术、腕管松解术、神经节囊肿切除术、De Quervain 腱鞘炎松解术、腕掌关节成形术或桡骨远端骨折、销钉术或切开复位/内固定术的患者,政策实施后每月使用治疗的几率没有明显变化。投保后,综合保险计划的总费用降低了 2%(95% 置信区间 [CI]:-0.03 至 -0.01,P < 0.001),独家医疗机构的总费用降低了 7%(95% 置信区间 [CI]:-0.10 至 -0.04,P < 0.001),HMO 的总费用降低了 1%(95% 置信区间 [CI]:-0.01 至 0.002,P = 0.01),首选医疗机构的总费用降低了 3%(95% 置信区间 [CI]:-0.03 至 -0.02,P < 0.001)。在投保后,综合保险计划、独家医疗服务提供者组织、健康维护组织、首选医疗服务提供者组织或按人头付费服务点保险计划的患者每月自付费用没有变化:结论:尽管净费用较低,但参加雇主赞助的医疗保险优势计划的患者的自付治疗费用却有所增加。这些数据突出表明,迫切需要制定相关政策,确保患者在总体医疗成本降低时能够受益。
{"title":"Employer-Sponsored Medicare Advantage Plans and the 2018 Therapy Cap Repeal: Reduced Overall Spending Does Not Constrain Out-of-Pocket Costs.","authors":"Joseph N Fahmy, Lingxuan Kong, Lu Wang, Kevin C Chung","doi":"10.1097/SAP.0000000000004074","DOIUrl":"10.1097/SAP.0000000000004074","url":null,"abstract":"<p><strong>Background: </strong>Policy impacting traditional Medicare beneficiaries may have unintended effects for privately insured patients. After the repeal of a longstanding $1500 outpatient therapy cap in 2018, we aimed to evaluate if this policy change was associated with differences in use of cost of postoperative therapy after common hand surgeries, including carpal tunnel release, trigger finger release, ganglion cyst excision, De Quervain tenosynovitis release, carpometacarpal arthroplasty, and distal radius fracture open reduction/internal fixation or percutaneous pinning.</p><p><strong>Methods: </strong>The Medicare Supplement and Coordination of Benefits files from Marketscan were used. Frequency of therapy appointments, overall costs, and out-of-pocket costs were obtained. A segmented interrupted time series with Poisson and log-transformed linear regression was performed.</p><p><strong>Results: </strong>No significant monthly change in odds of therapy use was found in the postpolicy period for patients who underwent trigger finger release, carpal tunnel release, Ganglion cyst excision, De Quervain tenosynovitis release, carpometacarpal arthroplasty, or distal radius fracture, pinning, or open reduction/internal fixation. Overall cost decreased in the postpolicy period by 2% for comprehensive plans (95% confidence interval [CI]: -0.03 to -0.01, P < 0.001), by 7% for those with exclusive provider organizations (95% CI: -0.10 to -0.04, P < 0.001), by 1% for HMOs (95% CI: -0.01 to 0.002, P = 0.01), and by 3% for preferred provider organizations (95% CI: -0.03 to -0.02, P < 0.001). In the postpolicy period, no monthly change in out-of-pocket cost was observed for patients with comprehensive, exclusive provider organization, health maintenance organization, preferred provider organization, or point of service with capitation insurance plans.</p><p><strong>Conclusions: </strong>Patients with employer-sponsored Medicare Advantage plans experienced increased out-of-pocket costs for therapy despite lower net costs. These data highlight an urgent need for policy ensuring that patients benefit when overall costs of care decrease.</p>","PeriodicalId":8060,"journal":{"name":"Annals of Plastic Surgery","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141992214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect of Bowel Anastomosis on Outcomes in Complex Abdominal Wall Reconstruction: A 10-Year Retrospective Cohort Study. 肠吻合对复杂腹壁重建术结果的影响:一项10年回顾性队列研究
IF 1.4 4区 医学 Q3 SURGERY Pub Date : 2024-08-01 Epub Date: 2024-07-02 DOI: 10.1097/SAP.0000000000004017
Orr Shauly, Troy Marxen, Ambika Menon, Savanah Rumbika, Makenna Ash, Omar Jean-Baptiste, Albert Losken

Background: In patients who require complex abdominal wall reconstruction (CAWR), the need for a bowel anastomosis could impact procedure choice and outcome. In this retrospective cohort study, we examine the effect of bowel anastomosis on complications and hernia recurrence.

Methods: All patients who underwent CAWR between 2011 and 2021 by the senior author were reviewed in a retrospective cohort analysis. Patients were included if they met the above criteria. Patients were excluded if they did not undergo the above procedure or if they underwent a different procedure simultaneously. Univariate analysis was performed for patients who underwent bowel anastomosis, and multiple variable logistic regression analysis was performed with respect to overall complications.

Results: A total of 264 patients underwent CAWR over a 10-year interval. A total of 41 patients underwent bowel anastomosis (16%), and 223 patients (84%) underwent CAWR without bowel anastomosis. Mean patient age was 55.50 ± 11.55 years. Mean patient body mass index was 32.36 ± 7.31 kg/m 2 . Mean follow-up time was 10.20 months. There was a significant difference in hernia repair etiology, with higher rates of recurrent hernia repair among patients receiving bowel anastomosis (odds ratio, 2.98; 95% confidence interval, 1.49-5.95; P = 0.0018). Acellular dermal matrix was used more frequently in patients who required a bowel anastomosis (odds ratio, 3.74; 95% confidence interval, 1.75-8.00; P = 0.0018). Major and minor complications were also significantly higher in this cohort. Regression analysis for overall complications revealed the presence of bowel anastomosis, fascial repair technique, and follow-up time as independent predictors of overall complications.

Conclusion: Bowel anastomosis performed at the time of CAWR significantly increased the rate of overall and major complications but did not predict hernia recurrence. Plastic surgeons should utilize this information in counseling patients and in deciding the most appropriate hernia repair technique.

背景:对于需要进行复杂腹壁重建(CAWR)的患者来说,是否需要进行肠吻合术可能会影响手术的选择和结果。在这项回顾性队列研究中,我们探讨了肠吻合术对并发症和疝复发的影响:在回顾性队列分析中,对资深作者在 2011 年至 2021 年间接受 CAWR 的所有患者进行了回顾性分析。符合上述标准的患者被纳入其中。未接受上述手术或同时接受其他手术的患者排除在外。对接受肠吻合术的患者进行了单变量分析,并对总体并发症进行了多变量逻辑回归分析:结果:10年间,共有264名患者接受了CAWR手术。共有41名患者接受了肠吻合术(16%),223名患者(84%)在接受CAWR手术时未进行肠吻合术。患者平均年龄为 55.50±11.55 岁。平均体重指数为(32.36±7.31)千克/平方米。平均随访时间为 10.20 个月。疝修补术的病因有明显差异,接受肠吻合术的患者复发疝修补术的比例更高(几率比,2.98;95% 置信区间,1.49-5.95;P = 0.0018)。需要进行肠吻合术的患者更常使用细胞真皮基质(几率比为 3.74;95% 置信区间为 1.75-8.00;P = 0.0018)。该组患者的主要和次要并发症发生率也明显较高。对总体并发症的回归分析显示,肠吻合术、筋膜修复技术和随访时间是总体并发症的独立预测因素:结论:在 CAWR 时进行肠吻合术会显著增加总并发症和主要并发症的发生率,但不能预测疝气复发。整形外科医生应利用这些信息为患者提供咨询,并决定最合适的疝修补技术。
{"title":"The Effect of Bowel Anastomosis on Outcomes in Complex Abdominal Wall Reconstruction: A 10-Year Retrospective Cohort Study.","authors":"Orr Shauly, Troy Marxen, Ambika Menon, Savanah Rumbika, Makenna Ash, Omar Jean-Baptiste, Albert Losken","doi":"10.1097/SAP.0000000000004017","DOIUrl":"10.1097/SAP.0000000000004017","url":null,"abstract":"<p><strong>Background: </strong>In patients who require complex abdominal wall reconstruction (CAWR), the need for a bowel anastomosis could impact procedure choice and outcome. In this retrospective cohort study, we examine the effect of bowel anastomosis on complications and hernia recurrence.</p><p><strong>Methods: </strong>All patients who underwent CAWR between 2011 and 2021 by the senior author were reviewed in a retrospective cohort analysis. Patients were included if they met the above criteria. Patients were excluded if they did not undergo the above procedure or if they underwent a different procedure simultaneously. Univariate analysis was performed for patients who underwent bowel anastomosis, and multiple variable logistic regression analysis was performed with respect to overall complications.</p><p><strong>Results: </strong>A total of 264 patients underwent CAWR over a 10-year interval. A total of 41 patients underwent bowel anastomosis (16%), and 223 patients (84%) underwent CAWR without bowel anastomosis. Mean patient age was 55.50 ± 11.55 years. Mean patient body mass index was 32.36 ± 7.31 kg/m 2 . Mean follow-up time was 10.20 months. There was a significant difference in hernia repair etiology, with higher rates of recurrent hernia repair among patients receiving bowel anastomosis (odds ratio, 2.98; 95% confidence interval, 1.49-5.95; P = 0.0018). Acellular dermal matrix was used more frequently in patients who required a bowel anastomosis (odds ratio, 3.74; 95% confidence interval, 1.75-8.00; P = 0.0018). Major and minor complications were also significantly higher in this cohort. Regression analysis for overall complications revealed the presence of bowel anastomosis, fascial repair technique, and follow-up time as independent predictors of overall complications.</p><p><strong>Conclusion: </strong>Bowel anastomosis performed at the time of CAWR significantly increased the rate of overall and major complications but did not predict hernia recurrence. Plastic surgeons should utilize this information in counseling patients and in deciding the most appropriate hernia repair technique.</p>","PeriodicalId":8060,"journal":{"name":"Annals of Plastic Surgery","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141562464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chronic Pain Following Breast Reconstruction: A Scoping Review. 乳房再造术后的慢性疼痛:范围综述。
IF 1.4 4区 医学 Q3 SURGERY Pub Date : 2024-08-01 Epub Date: 2024-07-05 DOI: 10.1097/SAP.0000000000003986
Makoto Shiraishi, Yoshihiro Sowa, Naoki Inafuku, Ataru Sunaga, Kotaro Yoshimura, Mutsumi Okazaki

Background: Breast cancer survival rates have increased significantly, underscoring the importance of enhancing long-term health-related quality of life. Breast reconstruction following mastectomy has emerged as a common approach that contributes to improved health-related quality of life. Nonetheless, chronic pain following breast reconstruction is a prevalent issue that has a negative impact on overall well-being.

Methods: To examine recent findings on chronic pain after breast reconstruction and progress in pain management, we performed a review of the literature through independent searches using the MEDLINE database within NIH National Library of Medicine PubMed.

Results: The review suggested that autologous reconstruction causes chronic postsurgical pain, especially at specific donor sites, whereas implant-based reconstruction does not seem to increase the risk of chronic pain. Moreover, certain operational and patient factors are also associated with chronic pain. Appropriate pain management can reduce chronic pain and prevent the transition from acute to chronic pain.

Conclusion: This scoping review evaluated the characteristics of long-term chronic pain after breast reconstruction. The findings provide patients with important treatment information and will assist with their decision on their preferred treatment.

背景:乳腺癌的存活率大幅提高,凸显了提高长期健康相关生活质量的重要性。乳房切除术后的乳房重建已成为有助于提高健康相关生活质量的常用方法。然而,乳房再造术后的慢性疼痛是一个普遍存在的问题,对整体健康有负面影响:为了研究乳房再造术后慢性疼痛的最新发现以及疼痛治疗的进展,我们通过使用美国国立卫生研究院国家医学图书馆 PubMed 中的 MEDLINE 数据库进行独立检索,对文献进行了综述:结果:综述表明,自体乳房再造会引起术后慢性疼痛,尤其是在特定的供体部位,而植入体乳房再造似乎不会增加慢性疼痛的风险。此外,某些操作和患者因素也与慢性疼痛有关。适当的疼痛管理可以减少慢性疼痛,防止从急性疼痛过渡到慢性疼痛:本范围性综述评估了乳房再造术后长期慢性疼痛的特征。研究结果为患者提供了重要的治疗信息,有助于他们决定首选的治疗方法。
{"title":"Chronic Pain Following Breast Reconstruction: A Scoping Review.","authors":"Makoto Shiraishi, Yoshihiro Sowa, Naoki Inafuku, Ataru Sunaga, Kotaro Yoshimura, Mutsumi Okazaki","doi":"10.1097/SAP.0000000000003986","DOIUrl":"10.1097/SAP.0000000000003986","url":null,"abstract":"<p><strong>Background: </strong>Breast cancer survival rates have increased significantly, underscoring the importance of enhancing long-term health-related quality of life. Breast reconstruction following mastectomy has emerged as a common approach that contributes to improved health-related quality of life. Nonetheless, chronic pain following breast reconstruction is a prevalent issue that has a negative impact on overall well-being.</p><p><strong>Methods: </strong>To examine recent findings on chronic pain after breast reconstruction and progress in pain management, we performed a review of the literature through independent searches using the MEDLINE database within NIH National Library of Medicine PubMed.</p><p><strong>Results: </strong>The review suggested that autologous reconstruction causes chronic postsurgical pain, especially at specific donor sites, whereas implant-based reconstruction does not seem to increase the risk of chronic pain. Moreover, certain operational and patient factors are also associated with chronic pain. Appropriate pain management can reduce chronic pain and prevent the transition from acute to chronic pain.</p><p><strong>Conclusion: </strong>This scoping review evaluated the characteristics of long-term chronic pain after breast reconstruction. The findings provide patients with important treatment information and will assist with their decision on their preferred treatment.</p>","PeriodicalId":8060,"journal":{"name":"Annals of Plastic Surgery","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141562524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Technical Pearls and Pitfalls of Facial Feminization Surgery: A Review of Techniques From a Single Institutional Practice. 面部女性化手术的技术要点和陷阱:单一机构手术技术回顾。
IF 1.4 4区 医学 Q3 SURGERY Pub Date : 2024-08-01 Epub Date: 2024-07-05 DOI: 10.1097/SAP.0000000000003989
Bachar F Chaya, Matteo Laspro, Jorge Trilles, Hilliard Brydges, David Tran, Danielle H Rochlin, Michael F Cassidy, Ricardo Rodriguez Colon, Eduardo D Rodriguez

Background: Facial feminization surgery (FFS) is an emerging practice that falls under the broader umbrella of gender-affirming surgery. Various approaches exist to feminize the face, yet few published articles describe in detail the techniques of each component procedure. Considering the diversity of interventions employed, the objective of this manuscript is to highlight FFS techniques utilized by the senior author and create a corresponding media gallery.

Methods: All patients with the diagnosis of gender dysphoria that were referred to the senior author for FFS consultation between June 2017 and August 2022 were reviewed. Data were retrospectively collected from electronic medical records according to the institutional review board (IRB)-approved study protocol. Data collected and analyzed included demographics, operative documentation, and postoperative follow-up. Multimedia material was collected intraoperatively and postoperatively.

Results: A total of 231 patients underwent 262 operations with a total of 1224 FFS procedures. The average follow-up time was 7.7 ± 11 months. Out of the 262 operations, 24 (9.2%) patients experienced minor complications, including 3 (1.1%) with wound dehiscence, 13 (5.0%) with hematomas, and 14 (5.3%) with postoperative infection requiring antibiotics. Of those, 3 (1.1%) required a return to the operating room for washout or removal of malar implants.

Conclusion: Although there is a consensus on the fundamental surgical principles to achieve adequate feminization of the facial architecture, the specific techniques to do so differ according to individual practices. As techniques diverge, so do their risk profiles and outcomes; techniques must, thus, align with patients' interventional goals. The material presented here is one of many that can support trainees and junior surgeons as they build a gender-affirming practice.

背景:面部女性化手术(FFS)是一种新兴的做法,属于更广泛的性别确认手术范畴。面部女性化手术的方法多种多样,但很少有公开发表的文章详细描述每种手术的技术。考虑到所采用的干预措施的多样性,本手稿的目的是重点介绍资深作者所使用的FFS技术,并创建一个相应的媒体库:对2017年6月至2022年8月期间转诊至资深作者处进行FFS咨询的所有诊断为性别障碍的患者进行回顾。根据机构审查委员会(IRB)批准的研究方案,从电子病历中回顾性收集数据。收集和分析的数据包括人口统计学、手术记录和术后随访。术中和术后收集了多媒体资料:结果:共有 231 名患者接受了 262 例手术,共进行了 1224 次全麻手术。平均随访时间为 7.7 ± 11 个月。在 262 例手术中,有 24 例(9.2%)患者出现了轻微并发症,包括 3 例(1.1%)伤口裂开、13 例(5.0%)血肿和 14 例(5.3%)术后感染,需要使用抗生素。其中,3 例(1.1%)需要返回手术室进行冲洗或取出假体:结论:尽管在实现面部结构适当女性化的基本手术原则上已达成共识,但具体操作技术却因人而异。随着技术的不同,其风险和结果也各不相同;因此,技术必须与患者的介入目标相一致。本文提供的资料是众多资料中的一份,可为受训者和初级外科医生建立性别平等实践提供支持。
{"title":"Technical Pearls and Pitfalls of Facial Feminization Surgery: A Review of Techniques From a Single Institutional Practice.","authors":"Bachar F Chaya, Matteo Laspro, Jorge Trilles, Hilliard Brydges, David Tran, Danielle H Rochlin, Michael F Cassidy, Ricardo Rodriguez Colon, Eduardo D Rodriguez","doi":"10.1097/SAP.0000000000003989","DOIUrl":"10.1097/SAP.0000000000003989","url":null,"abstract":"<p><strong>Background: </strong>Facial feminization surgery (FFS) is an emerging practice that falls under the broader umbrella of gender-affirming surgery. Various approaches exist to feminize the face, yet few published articles describe in detail the techniques of each component procedure. Considering the diversity of interventions employed, the objective of this manuscript is to highlight FFS techniques utilized by the senior author and create a corresponding media gallery.</p><p><strong>Methods: </strong>All patients with the diagnosis of gender dysphoria that were referred to the senior author for FFS consultation between June 2017 and August 2022 were reviewed. Data were retrospectively collected from electronic medical records according to the institutional review board (IRB)-approved study protocol. Data collected and analyzed included demographics, operative documentation, and postoperative follow-up. Multimedia material was collected intraoperatively and postoperatively.</p><p><strong>Results: </strong>A total of 231 patients underwent 262 operations with a total of 1224 FFS procedures. The average follow-up time was 7.7 ± 11 months. Out of the 262 operations, 24 (9.2%) patients experienced minor complications, including 3 (1.1%) with wound dehiscence, 13 (5.0%) with hematomas, and 14 (5.3%) with postoperative infection requiring antibiotics. Of those, 3 (1.1%) required a return to the operating room for washout or removal of malar implants.</p><p><strong>Conclusion: </strong>Although there is a consensus on the fundamental surgical principles to achieve adequate feminization of the facial architecture, the specific techniques to do so differ according to individual practices. As techniques diverge, so do their risk profiles and outcomes; techniques must, thus, align with patients' interventional goals. The material presented here is one of many that can support trainees and junior surgeons as they build a gender-affirming practice.</p>","PeriodicalId":8060,"journal":{"name":"Annals of Plastic Surgery","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141562535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neural and Inflammatory Interactions in Wound Healing. 伤口愈合中的神经与炎症相互作用
IF 1.4 4区 医学 Q3 SURGERY Pub Date : 2024-08-01 DOI: 10.1097/SAP.0000000000003933
Junhao Zeng, Yuyan Pan, Sara C Chaker, Ricardo Torres-Guzman, William C Lineaweaver, Fazhi Qi

Abstract: The skin is an intricate network of both neurons and immunocytes, where emerging evidence has indicated that the regulation of neural-inflammatory processes may play a crucial role in mediating wound healing. Disease associated abnormal immunological dysfunction and peripheral neuropathy are implicated in the pathogenesis of wound healing impairment. However, the mechanisms through which neural-inflammatory interactions modulate wound healing remain ambiguous. Understanding the underlying mechanisms may provide novel insights to develop therapeutic devices, which could manipulate neural-inflammatory crosstalk to aid wound healing. This review aims to comprehensively illustrate the neural-inflammatory interactions during different stages of the repair process. Numerous mediators including neuropeptides secreted by the sensory and autonomic nerve fibers and cytokines produced by immunocytes play an essential part during the distinct phases of wound healing.

摘要:皮肤是一个由神经元和免疫细胞组成的复杂网络,新的证据表明,神经-炎症过程的调节可能在介导伤口愈合方面发挥着至关重要的作用。与疾病相关的异常免疫功能障碍和周围神经病变与伤口愈合障碍的发病机制有关。然而,神经-炎症相互作用调节伤口愈合的机制仍不明确。了解其基本机制可为开发治疗设备提供新的见解,从而操纵神经-炎症串扰来帮助伤口愈合。本综述旨在全面阐述修复过程不同阶段的神经-炎症相互作用。包括感觉和自主神经纤维分泌的神经肽以及免疫细胞产生的细胞因子在内的多种介质在伤口愈合的不同阶段发挥着重要作用。
{"title":"Neural and Inflammatory Interactions in Wound Healing.","authors":"Junhao Zeng, Yuyan Pan, Sara C Chaker, Ricardo Torres-Guzman, William C Lineaweaver, Fazhi Qi","doi":"10.1097/SAP.0000000000003933","DOIUrl":"10.1097/SAP.0000000000003933","url":null,"abstract":"<p><strong>Abstract: </strong>The skin is an intricate network of both neurons and immunocytes, where emerging evidence has indicated that the regulation of neural-inflammatory processes may play a crucial role in mediating wound healing. Disease associated abnormal immunological dysfunction and peripheral neuropathy are implicated in the pathogenesis of wound healing impairment. However, the mechanisms through which neural-inflammatory interactions modulate wound healing remain ambiguous. Understanding the underlying mechanisms may provide novel insights to develop therapeutic devices, which could manipulate neural-inflammatory crosstalk to aid wound healing. This review aims to comprehensively illustrate the neural-inflammatory interactions during different stages of the repair process. Numerous mediators including neuropeptides secreted by the sensory and autonomic nerve fibers and cytokines produced by immunocytes play an essential part during the distinct phases of wound healing.</p>","PeriodicalId":8060,"journal":{"name":"Annals of Plastic Surgery","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141888283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Experience in Lower Eyelid Blepharoplasty: Improvement of Surgical Procedures Based on Anatomical Basis. 下眼睑眼睑成形术的经验:以解剖学为基础改进手术程序。
IF 1.4 4区 医学 Q3 SURGERY Pub Date : 2024-08-01 DOI: 10.1097/SAP.0000000000003890
Jinxiu Yang, Leren He

Objective: This study characterizes the appearance changes associated with aging of the human lower eyelid, grounded in its anatomical basis. Tailored approaches to lower eyelid bag are performed by these anatomical manifestations.

Methods: From January 2017 to January 2023, lower eyelid blepharoplasty was performed on 137 patients, aged 20 to 60 years. These patients were divided into 3 groups according to the periorbital aging appearance, primarily characterized by the presence and location of the "bag" bulge of the lower eyelid. We analyzed the corresponding changes in anatomical structures for each type, which included a weakened fibrous orbital support system, reduced muscle tone, and increased orbital fat. Patients were treated with tailored blepharoplasty techniques according to their classification. All patients in this study ranged in follow-up from 1 to 12 months. With patients' permit, photographs and clinical information were taken to evaluate the preoperative and postoperative outcome.

Results: Our study identified 3 morphologies of the lower eyelid. Type 1 presents a "bubble bag" in the medial and inferior aspect of the lower eyelid. Type 2 features a double convexity contour, with separate fat pad herniations demarcated by fibrous connective tissue. Type 3 exhibits a single convexity with a uniform herniation of fat pads across the entire lower eyelid. We have delineated the anatomical changes associated with each morphology type. With an approach grounded in "remodeling" and "recovery," the surgical treatment targets the fibrous support tissue to improve the outcomes of lower eyelid rejuvenation. No complications occurred. All postoperative results reached both surgeon's and patient's expectations.

Conclusions: Surgeons must recognize the pivotal role of fibrous connective tissues-including the arcuate expansion, fascia of the inferior oblique muscle, and the orbicularis retaining ligament-and endeavor to preserve or reinforce these structures during surgical procedures. An anatomically based surgical approach would more effectively and safely to resist the facial aging process.

研究目的本研究以解剖学为基础,描述与人体下眼睑衰老相关的外观变化。根据这些解剖学表现,为下睑眼袋的治疗提供量身定制的方法:2017年1月至2023年1月,对137名年龄在20至60岁之间的患者进行了下睑眼袋整形术。这些患者根据眶周老化外观分为 3 组,主要特征是下眼睑 "眼袋 "隆起的存在和位置。我们分析了每种类型的解剖结构的相应变化,包括眼眶纤维支撑系统减弱、肌肉张力降低和眼眶脂肪增加。根据患者的分类,我们为他们量身定制了眼睑整形技术。本研究中所有患者的随访时间从 1 个月到 12 个月不等。在患者的许可下,我们拍摄了照片和临床资料,以评估术前和术后效果:我们的研究确定了下眼睑的三种形态。结果:我们的研究发现了下眼睑的三种形态:第一种是在下眼睑的内侧和下侧有一个 "气泡袋"。第二种是双凸轮廓,脂肪垫疝出由纤维结缔组织分开。第 3 型表现为单凸轮廓,整个下眼睑的脂肪垫均匀疝出。我们已经描述了与每种形态类型相关的解剖学变化。手术治疗以 "重塑 "和 "恢复 "为基础,以纤维支撑组织为目标,改善下眼睑年轻化的效果。无并发症发生。所有术后效果均达到了外科医生和患者的预期:外科医生必须认识到纤维结缔组织(包括弧形扩张肌、下斜肌筋膜和眼轮匝肌固定韧带)的关键作用,并在手术过程中努力保留或加固这些结构。以解剖学为基础的手术方法将更有效、更安全地抵御面部衰老过程。
{"title":"The Experience in Lower Eyelid Blepharoplasty: Improvement of Surgical Procedures Based on Anatomical Basis.","authors":"Jinxiu Yang, Leren He","doi":"10.1097/SAP.0000000000003890","DOIUrl":"10.1097/SAP.0000000000003890","url":null,"abstract":"<p><strong>Objective: </strong>This study characterizes the appearance changes associated with aging of the human lower eyelid, grounded in its anatomical basis. Tailored approaches to lower eyelid bag are performed by these anatomical manifestations.</p><p><strong>Methods: </strong>From January 2017 to January 2023, lower eyelid blepharoplasty was performed on 137 patients, aged 20 to 60 years. These patients were divided into 3 groups according to the periorbital aging appearance, primarily characterized by the presence and location of the \"bag\" bulge of the lower eyelid. We analyzed the corresponding changes in anatomical structures for each type, which included a weakened fibrous orbital support system, reduced muscle tone, and increased orbital fat. Patients were treated with tailored blepharoplasty techniques according to their classification. All patients in this study ranged in follow-up from 1 to 12 months. With patients' permit, photographs and clinical information were taken to evaluate the preoperative and postoperative outcome.</p><p><strong>Results: </strong>Our study identified 3 morphologies of the lower eyelid. Type 1 presents a \"bubble bag\" in the medial and inferior aspect of the lower eyelid. Type 2 features a double convexity contour, with separate fat pad herniations demarcated by fibrous connective tissue. Type 3 exhibits a single convexity with a uniform herniation of fat pads across the entire lower eyelid. We have delineated the anatomical changes associated with each morphology type. With an approach grounded in \"remodeling\" and \"recovery,\" the surgical treatment targets the fibrous support tissue to improve the outcomes of lower eyelid rejuvenation. No complications occurred. All postoperative results reached both surgeon's and patient's expectations.</p><p><strong>Conclusions: </strong>Surgeons must recognize the pivotal role of fibrous connective tissues-including the arcuate expansion, fascia of the inferior oblique muscle, and the orbicularis retaining ligament-and endeavor to preserve or reinforce these structures during surgical procedures. An anatomically based surgical approach would more effectively and safely to resist the facial aging process.</p>","PeriodicalId":8060,"journal":{"name":"Annals of Plastic Surgery","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141888288","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Commentary on "Clinical Efficacy, Safety, and Complications of the Arthroscopic Cartilage Shaving Procedure for Secondary Osmidrosis Treatment". 关于 "关节镜下软骨刮除手术治疗继发性 Osmidrosis 的临床疗效、安全性和并发症 "的评论。
IF 1.4 4区 医学 Q3 SURGERY Pub Date : 2024-08-01 Epub Date: 2024-05-22 DOI: 10.1097/SAP.0000000000003993
Wen-Tsao Ho
{"title":"Commentary on \"Clinical Efficacy, Safety, and Complications of the Arthroscopic Cartilage Shaving Procedure for Secondary Osmidrosis Treatment\".","authors":"Wen-Tsao Ho","doi":"10.1097/SAP.0000000000003993","DOIUrl":"10.1097/SAP.0000000000003993","url":null,"abstract":"","PeriodicalId":8060,"journal":{"name":"Annals of Plastic Surgery","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141074770","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnosis and Treatment of Skin Lesions in Renal Transplant Recipients: A Retrospective Review. 肾移植受者皮肤病变的诊断和治疗:回顾性综述。
IF 1.4 4区 医学 Q3 SURGERY Pub Date : 2024-08-01 DOI: 10.1097/SAP.0000000000003930
Yining Ge, Mariam Saad, Sriya Nemani, Yuedong Shi, William C Lineaweaver, Yanwen Yang

Background: Immunosuppressive therapy is essential for to prevent graft rejection in renal transplant patients; however, it is associated with elevating the risk of several pathologies in these patients particularly infectious and neoplastic conditions. In this study, we explore the diagnosis and treatment of skin lesions in renal transplant patients.

Methods: A retrospective chart review of 12 renal transplant recipients referred to plastic and reconstructive surgery with skin lesions from 2000 to 2020 was performed.

Results: The mean age of the 12 patients was 49.6 years. Time to plastic surgery after renal transplantation ranged between 1 and 16 years. Nine cases of basal cell carcinoma, 2 cases of squamous cell carcinoma, and 1 case of skin and soft tissue infection of the lower extremity and cutaneous extranodal NK/T-cell lymphoma, nasal type was observed. Flaps, skin grafts, and artificial dermis grafts constitute the main reconstructive methods. There were no postoperative infections or wound dehiscence.

Conclusions: Cutaneous infections and skin malignancy account for most of the skin lesions developing after renal transplantation. Posttransplant lymphoproliferative disorder warrants equal attention and should not be disregarded. Early diagnosis and treatment significantly improve prognosis as patients with longer duration of transplant were found to have more aggressive tumors. Plastic and reconstructive surgery offers a safe therapeutic method of treatment in these cases.

背景:免疫抑制治疗是防止肾移植患者发生移植物排斥反应的必要手段,但同时也会增加这些患者发生多种病变的风险,尤其是感染性和肿瘤性疾病。在本研究中,我们探讨了肾移植患者皮肤病变的诊断和治疗:方法:我们对 2000 年至 2020 年期间因皮肤损伤转诊至整形外科的 12 名肾移植受者进行了回顾性病历审查:结果:12名患者的平均年龄为49.6岁。结果:12 名患者的平均年龄为 49.6 岁,肾移植后接受整形手术的时间为 1 至 16 年。观察到 9 例基底细胞癌、2 例鳞状细胞癌、1 例下肢皮肤和软组织感染以及鼻型皮肤外结节性 NK/T 细胞淋巴瘤。皮瓣、植皮和人工真皮移植是主要的重建方法。术后无感染和伤口裂开:结论:皮肤感染和皮肤恶性肿瘤是肾移植术后皮肤损伤的主要原因。移植后淋巴增生性疾病同样值得关注,不应被忽视。由于移植时间较长的患者肿瘤侵袭性更强,因此早期诊断和治疗可明显改善预后。整形和重建手术为这些病例提供了一种安全的治疗方法。
{"title":"Diagnosis and Treatment of Skin Lesions in Renal Transplant Recipients: A Retrospective Review.","authors":"Yining Ge, Mariam Saad, Sriya Nemani, Yuedong Shi, William C Lineaweaver, Yanwen Yang","doi":"10.1097/SAP.0000000000003930","DOIUrl":"10.1097/SAP.0000000000003930","url":null,"abstract":"<p><strong>Background: </strong>Immunosuppressive therapy is essential for to prevent graft rejection in renal transplant patients; however, it is associated with elevating the risk of several pathologies in these patients particularly infectious and neoplastic conditions. In this study, we explore the diagnosis and treatment of skin lesions in renal transplant patients.</p><p><strong>Methods: </strong>A retrospective chart review of 12 renal transplant recipients referred to plastic and reconstructive surgery with skin lesions from 2000 to 2020 was performed.</p><p><strong>Results: </strong>The mean age of the 12 patients was 49.6 years. Time to plastic surgery after renal transplantation ranged between 1 and 16 years. Nine cases of basal cell carcinoma, 2 cases of squamous cell carcinoma, and 1 case of skin and soft tissue infection of the lower extremity and cutaneous extranodal NK/T-cell lymphoma, nasal type was observed. Flaps, skin grafts, and artificial dermis grafts constitute the main reconstructive methods. There were no postoperative infections or wound dehiscence.</p><p><strong>Conclusions: </strong>Cutaneous infections and skin malignancy account for most of the skin lesions developing after renal transplantation. Posttransplant lymphoproliferative disorder warrants equal attention and should not be disregarded. Early diagnosis and treatment significantly improve prognosis as patients with longer duration of transplant were found to have more aggressive tumors. Plastic and reconstructive surgery offers a safe therapeutic method of treatment in these cases.</p>","PeriodicalId":8060,"journal":{"name":"Annals of Plastic Surgery","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141888281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rosacea Epidemiological Investigation and Etiology Exploration in the Plateau Area. 高原地区红斑痤疮流行病学调查与病因探索。
IF 1.4 4区 医学 Q3 SURGERY Pub Date : 2024-08-01 DOI: 10.1097/SAP.0000000000003999
Weidong Wen, Colin Dahl, Yong Zhang

Background: The epidemiology of 2 neighboring cities of differing altitude in Northwest China is unknown. The present study investigated the prevalence of rosacea in a high-altitude city and a low-altitude city.

Methods: The prevalence study was conducted via clinical examination of male and female participants in the following age groups: 5-17, 18-30, 31-50, and 51-70 years. Rosacea subtype was also determined as erythematotelangiectatic rosacea (ETTR) or papulopustular rosacea (PPR).

Results: The rosacea prevalence (RP) in the low-altitude city was 33.8% ± 1.2% (95% CI, ETTR = 1794, PPR = 174, n = 5794). RP in the high-altitude city has a notably higher reading of 47.7% ± 1.4% (95% CI, ETTR = 2090, PPR = 219, n = 4796). In both cities, the ETTR subtype predominated, and there was marked increase in RP among females. RP in low-altitude city females was steady across all age groups, while RP in low-altitude city males showed a declining trend with age. RP in high-altitude city females indicated a slightly increasing trend with age, while RP in males again showed a declining trend with age. Based on the results of this high-altitude city and low-altitude city study, there are an estimated 2.1 million people with rosacea, from 2 cities with a total population of 5.4 million.

Conclusions: Due to the high altitude and accompanying increased UV radiation, cold climate, and reduced oxygen density, the greater northwest region of China is expected to experience high RP rates.

背景:中国西北地区海拔不同的两个相邻城市的流行病学尚不清楚。本研究调查了一个高海拔城市和一个低海拔城市的酒渣鼻患病率:方法:本研究通过对以下年龄组的男女参与者进行临床检查来进行患病率研究:5-17 岁、18-30 岁、31-50 岁和 51-70 岁。红斑痤疮亚型也被确定为红斑扩张性红斑痤疮(ETTR)或丘疹脓疱性红斑痤疮(PPR):低海拔城市的酒糟鼻患病率(RP)为33.8% ± 1.2%(95% CI,ETTR = 1794,PPR = 174,n = 5794)。高海拔城市的 RP 读数明显更高,为 47.7% ± 1.4%(95% CI,ETTR = 2090,PPR = 219,n = 4796)。在这两个城市中,ETTR 亚型占主导地位,女性的 RP 显著增加。低海拔城市女性的 RP 在所有年龄组中都保持稳定,而低海拔城市男性的 RP 则随着年龄的增长呈下降趋势。高海拔城市女性的 RP 随年龄略有增加,而男性的 RP 则随年龄呈下降趋势。根据这项高海拔城市和低海拔城市研究的结果,在两个总人口为 540 万的城市中,估计有 210 万人患有红斑痤疮:结论:由于海拔高,紫外线辐射增加,气候寒冷,氧气密度降低,预计中国大西北地区的红斑痤疮发病率较高。
{"title":"Rosacea Epidemiological Investigation and Etiology Exploration in the Plateau Area.","authors":"Weidong Wen, Colin Dahl, Yong Zhang","doi":"10.1097/SAP.0000000000003999","DOIUrl":"10.1097/SAP.0000000000003999","url":null,"abstract":"<p><strong>Background: </strong>The epidemiology of 2 neighboring cities of differing altitude in Northwest China is unknown. The present study investigated the prevalence of rosacea in a high-altitude city and a low-altitude city.</p><p><strong>Methods: </strong>The prevalence study was conducted via clinical examination of male and female participants in the following age groups: 5-17, 18-30, 31-50, and 51-70 years. Rosacea subtype was also determined as erythematotelangiectatic rosacea (ETTR) or papulopustular rosacea (PPR).</p><p><strong>Results: </strong>The rosacea prevalence (RP) in the low-altitude city was 33.8% ± 1.2% (95% CI, ETTR = 1794, PPR = 174, n = 5794). RP in the high-altitude city has a notably higher reading of 47.7% ± 1.4% (95% CI, ETTR = 2090, PPR = 219, n = 4796). In both cities, the ETTR subtype predominated, and there was marked increase in RP among females. RP in low-altitude city females was steady across all age groups, while RP in low-altitude city males showed a declining trend with age. RP in high-altitude city females indicated a slightly increasing trend with age, while RP in males again showed a declining trend with age. Based on the results of this high-altitude city and low-altitude city study, there are an estimated 2.1 million people with rosacea, from 2 cities with a total population of 5.4 million.</p><p><strong>Conclusions: </strong>Due to the high altitude and accompanying increased UV radiation, cold climate, and reduced oxygen density, the greater northwest region of China is expected to experience high RP rates.</p>","PeriodicalId":8060,"journal":{"name":"Annals of Plastic Surgery","volume":null,"pages":null},"PeriodicalIF":1.4,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141888286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of Plastic Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1